Evidence map›Paper›PMID 40113640›Full record

ReviewCardiovascular toxicology2025

Pharmacotherapeutic Strategies for Fine Particulate Matter-Induced Lung and Cardiovascular Damage: Marketed Drugs, Traditional Chinese Medicine, and Biological Agents.

Shuiqing Qu, Yan Liang, Shuoqiu Deng, Yu Li, Yuanmin Yang, Tuo Liu, Lina Chen, Yujie Li

Abstract readReview
PubMed Publisher
In one paragraph

Review in Cardiovascular toxicology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Shuiqing Qu *Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Yan Liang *Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Shuoqiu DengInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Yu LiInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Yuanmin YangInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Tuo LiuInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Lina ChenInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Yujie LiInstitute of Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing, 100700, China. yjli@icmm.ac.cn.

Funding

CACMS Innovation Fund CI2021A04611CACMS Innovation Fund CI2021A05106Fundamental Research Funds for the Central Public Welfare Research Institutes L2022035Scientific and Technological Innovation Project of China Academy of Chinese Medical Sciences CI2021B015
6 · The paper itself

Abstract

Fine particulate matter (PM

Indexed as

Air PollutantsBiological FactorsCardiovascular DiseasesLungLung DiseasesLung InjuryMedicine, Chinese TraditionalParticulate MatterAnimalsHumansInhalation ExposureParticle SizeAir PollutantsBiological FactorsParticulate MatterAir pollutionCardiovascular injuryFine particulate matterMedical therapyPulmonary injury

Identifiers

PMID40113640

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.